How have RDGL shares performed in 2024?

Vivos' stock was trading at $0.0723 at the start of the year. Since then, RDGL stock has increased by 42.6% and is now trading at $0.1031. View the best growth stocks for 2024 here .

Are investors shorting Vivos?

Vivos saw a increase in short interest in March. As of March 31st, there was short interest totaling 104,000 shares, an increase of 303.1% from the March 15th total of 25,800 shares. Based on an average daily trading volume, of 634,500 shares, the short-interest ratio is presently 0.2 days. View Vivos' Short Interest .

When is Vivos' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our RDGL earnings forecast .

How were Vivos' earnings last quarter?

Vivos Inc. (OTCMKTS:RDGL) released its earnings results on Monday, March, 18th. The company reported ($0.01) EPS for the quarter.

How do I buy shares of Vivos?

Shares of RDGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:RDGL

Vivos (RDGL) Stock Price, News & Analysis

→ Now Open: Crypto emergency update (From InvestorPlace) (Ad)

Free RDGL Stock Alerts

$0.10

0.00 (0.00%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.10
▼
$0.11
50-Day Range: $0.05
▼
$0.11
52-Week Range: $0.04
▼
$0.12

Volume: 501,366 shs
Average Volume: 721,841 shs
Market Capitalization: $40.09 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Financials Headlines SEC Filings Short Interest

Get Vivos alerts:

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Vivos Stock (OTCMKTS:RDGL)

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States and internationally. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.

RDGL Stock Price History

30 days | 90 days | 365 days | Advanced Chart

RDGL Stock News Headlines

April 15, 2024 | morningstar.com

Vivos Inc RDGL

April 11, 2024 | finanznachrichten.de

Vivos Therapeutics, Inc: Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement

April 19, 2024 | InvestorPlace (Ad)

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

April 11, 2024 | americanbankingnews.com

Short Interest in Vivos Inc. (OTCMKTS:RDGL) Increases By 303.1%

March 23, 2024 | benzinga.com

Vivos Stock (OTC:RDGL), Quotes and News Summary

February 23, 2024 | thestreet.com

Vivos Inc

February 22, 2024 | investorplace.com

3 Stocks to Turn $1,000 Into $1 Million: February 2024

January 31, 2024 | theglobeandmail.com

Speculation Tuesday: 2 Call Options and 1 Penny Stock to Consider

April 19, 2024 | InvestorPlace (Ad)

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

December 21, 2023 | msn.com

New Hope In Cancer Battle: FDA Grants Breakthrough Device Status To Vivos Inc.'s RadioGel

December 20, 2023 | finance.yahoo.com

Radiogel Precision Radionuclide Therapy Receives FDA Breakthrough Device Designation

December 20, 2023 | finance.yahoo.com

Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation

August 7, 2023 | finance.yahoo.com

Vivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional Clinics

May 15, 2023 | finance.yahoo.com

Vivos Inc. (RDGL) Stock Historical Prices & Data - Yahoo Finance

January 11, 2023 | finance.yahoo.com

Vivos Inc Files a New Patent on Alternate Particles for Precision Radionuclide Therapy

January 5, 2023 | reuters.com

RDGL.PK - Vivos Inc | Stock Price & Latest News | Reuters

January 3, 2023 | finance.yahoo.com

Vivos Inc Files a New Patent on Precision Radionuclide Therapy Support System Equipment

September 15, 2022 | stockhouse.com

Vivos Inc Files a New Patent on the Hydrogel Component of IsoPet®/RadioGel(TM)

September 14, 2022 | finance.yahoo.com

Vivos Inc Files a New Patent on the Hydrogel Component of IsoPet®/RadioGel™

August 18, 2022 | nz.finance.yahoo.com

Dua Lipa's LBD Looked Like a Pair of Pants With Straps

August 16, 2022 | uk.investing.com

Great Elm Group And 3 Other Stocks Under $5 Insiders Are Aggressively Buying

August 16, 2022 | finance.yahoo.com

Vivos Inc. Announces a New IsoPet® Precision Radionuclide Therapy Regional Clinic for Equine Therapy

July 15, 2022 | benzinga.com

Vivos (OTC:RDGL), Analyst Ratings, Price Targets, Predictions

July 14, 2022 | benzinga.com

Vivos (OTC:RDGL), Earnings Estimates, EPS, and Revenue

May 12, 2022 | finance.yahoo.com

Vivos Inc. Provides Intellectual Property Protection Update

April 21, 2022 | apnews.com

Vivos Inc Implements Multiple Patient IsoPet® Therapy Day

February 24, 2022 | finance.yahoo.com

Vivos Inc. Enhances its Intellectual Property Protection

See More Headlines

Receive RDGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vivos and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/18/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/02/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Finance
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: OTCMKTS:RDGL
CUSIP: N/A
CIK: 1449349
Web: www.radiogel.com
Phone: (509) 736-4000
Fax: 509-736-4007
Employees: 1
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-2,890,000.00
Net Margins: -9,524.89%
Pretax Margin: -14,846.15%
Return on Equity: N/A
Return on Assets: -180.12%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 6.57
Quick Ratio: 6.57

Sales & Book Value

Annual Sales: $20,000.00
Price / Sales: 2,004.62
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.02) per share
Price / Book: -5.16

Miscellaneous

Outstanding Shares: 388,870,000
Free Float: 316,930,000
Market Cap: $40.09 million
Optionable: Not Optionable
Beta: 1.53

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Dr. Michael K. Korenko Ph.D. (Age 78)
CEO, President & Director
Comp: $266.39k
Dr. Carlton M. Cadwell D.D.S. (Age 79)
Independent Chairman & Secretary
Dr. David J. Swanberg M.S. (Age 67)
P.E., Chief Technical Manager
Dr. Nigel R. Stevenson B.Sc.
Ph.D., Chief Science Officer
Dr. Fu-Min Su
Chief Radio Chemist & Radiation Safety Officer

Key Competitors

View All Competitors

RDGL Stock Analysis - Frequently Asked Questions

How have RDGL shares performed in 2024?: Vivos' stock was trading at $0.0723 at the start of the year. Since then, RDGL stock has increased by 42.6% and is now trading at $0.1031.
View the best growth stocks for 2024 here.
Are investors shorting Vivos?: Vivos saw a increase in short interest in March. As of March 31st, there was short interest totaling 104,000 shares, an increase of 303.1% from the March 15th total of 25,800 shares. Based on an average daily trading volume, of 634,500 shares, the short-interest ratio is presently 0.2 days.
View Vivos' Short Interest.
When is Vivos' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our RDGL earnings forecast.

How were Vivos' earnings last quarter?: Vivos Inc. (OTCMKTS:RDGL) released its earnings results on Monday, March, 18th. The company reported ($0.01) EPS for the quarter.
How do I buy shares of Vivos?: Shares of RDGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:RDGL) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Vivos (RDGL) Stock Price, News & Analysis

About Vivos Stock (OTCMKTS:RDGL)

RDGL Stock Price History

RDGL Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

RDGL Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info